06/11/2025 22:11
|
Medical, Health & Aged Care
* Third quarter total revenues increased 41% to $1.4 billion versus third quarter 2024
* Global BRUKINSA® (zanubrutinib) revenues increased 51% to $1.0 billion versus third quarter...